Evaluation of Micropulse Transscleral Cyclophotocoagulation in Management of Primary Open Angle Glaucoma

Abstract

Background: Glaucoma describes a group of eye illnesses in which there is progressive damage to the optic nerve, leading to impaired vision.
Aim: To evaluate the safety and efficiency of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC), in lowering IOP in cases that have 1ry open-angle glaucoma.
Patients and methods: This was a prospective, non-comparative interventional case series that was conducted on cases aged forty and older with 1ry open-angle glaucoma, whether controlled or uncontrolled, at the Memorial Institute of Ophthalmic Research in Cairo.
Results: The mean age was 63.86±13.26; there were seventeen cases (56.7%) that were men, and thirteen cases (43.3%) were women. The included right laterality eyes were 18 (56.7%). According to glaucoma severity, 2 patients (6.7%) were mild, 24 patients (80%) were moderate, 3 patients (10%) were advanced, and 1 patient (3.3%) was mild. There were 8 patients (26.7%) who had transient mydriasis, 3 patients (10%) who had inflammatory reaction in the anterior chamber, 2 patients (6.7%) who had subconjunctival hemorrhage, 2 patients (6.7%) who had IOP spikes, 2 patients (6.7%) who had cataract progression, 1 patient (3.3%) who had vision loss ≥ 2 lines, 1 patient (3.3%) who had mild hypotony, 3 patients (10%) who had pain during the procedure, and 2 patients (6.7%) who had pain during the early postoperative period.
Conclusion: The Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) effectively reduces IOP and medication burden in cases with mild-to-end-stage POAG, with minimal vision-threatening complications.